The life sciences industry is both driven and united by its need for speed to market, product reliability and economics. Pall Corporation's leading edge technologies and services play an essential and pivotal role in this industry's ability to achieve these goals.

Pall is the leading global provider of filtration, purification and separation technologies to the diverse and rapidly expanding Life Sciences market. Its products are used from the earliest stages of discovery and development of new drugs, through production and delivery of therapies for the prevention, diagnosis and treatment of disease.

In the laboratory, Pall products help to facilitate the drug discovery and development process to get innovative drugs to the market faster. In Biopharmaceuticals, Pall products are applicable to laboratory and pilot-scale development, aseptic processing, biologicals, bioprocessing, fermentation and downstream processing. In medical and transfusion medicine, Pall is the market leader in blood filtration systems to improve the quality and safety of the world's blood supply, and in medical filters that enhance the safety of cardiac surgery, drug delivery, intravenous feeding and the accuracy of diagnostic tests.

Pall life Sciences provides membrane and membrane devices to optimize detection and sample preparation in basic drug research, clinical diagnostics, combinatorial chemistry and high throughput screening, as well as in the growing genomics and proteomics markets.

In pharmaceutical and bioprocess manufacturing, Pall's direct and tangential flow filtration technologies are used for biomass removal, clarification, particulate and bioburden reduction, prefiltration, sterile filtration of liquids and gases, mycoplasma and virus clearance, endotoxin and DNA removal, and biomolecule purification and concentration. Products range from small laboratory scale devices to large automated systems and filter test instruments.

Pall maintains manufacturing facilities certified to ISO9001 in the United States, Puerto Rico, England, Ireland, Germany, Japan, India and China.

Pall's Scientific and Laboratory Services, and Validation Laboratory groups have been a cornerstone of support to our customers for more than 30 years. We employ more than 400 scientists, engineers and technicians in fully equipped laboratories in the Americas, Europe, Australia and Asia.

Major Products

• AcroWell™ and AcroPrep™ multiwell filter plates
  
• Ultrafiltration and centrifugal devices
  
• Chemiluminescent detection kits
  
• Pallchek™ luminometer for rapid microbiological contamination monitoring
  
• Acrodisc® Premium syringe filters for automated sample preparation
  
• UpScale™ program of scalable filtration products for direct flow and tangential flow filtration
  
• Mustang™ chromatography line of membrane adsorbers
  
• Resolute®* chromatography columns, processing and packing systems
  
• Ultipor® VF virus filters and automated virus reduction systems
  
• Palltronic™ Flowstar and Aquawit automated filter test instruments
  
• Filter Manager for process development and downscale studies
  
• NovaSip™ self-contained, disposable, steam-in-place capsule assemblies
  
• Kleenpak™ filter capsules, available autoclavable, gamma-irradiatable and pre-sterilized
  
• Disposable bioprocessing systems including filter capsules, process bags, aseptic connectors – pre-assembled with tubing and valves as required
  
• Supor® TFF cell harvesting cassettes and systems
  
• Membralox® ceramic TFF modules and systems
  
• SupraDisc™ and SupraDisc™ II lenticular filters
  
• Omega™ and Regen™ ultrafiltration cassettes and membranes
  
• Microza®* hollow fiber ultrafilters, perfusion systems, and harvest microfilters

® indicates a Pall trademark registered in the USA and ™ a Pall trademark, except Resolute which is a trademark of the Euroflow Group (UK), and Microza which is a registered trademark of Asahi Kasei (Japan).

Articles from Bioprocess International

• Applying Good Engineering Practices To The Design Of Single-Use Systems
  
• Introducing Disposable Systems Into Biomanufacturing
  
• A Prescriptive Approach To Management Of Solid Waste From Single-Use Systems
  
• Implementing Single-Use Technology In Biopharmaceutical Manufacturing
  
• Managing Solid Waste From Single- Use Systems In Biopharmaceutical Manufacturing
  
• Environmental Impact Of Single-Use And Reusable Bioprocess Systems

---

Click to see what was new with Pall Life Sciences – At INTERPHEX New York 2010! Pall Life Sciences – At INTERPHEX New York 2010, Ian Sellick from Pall Life Sciences introduces the new Cadence filtration system. This unique technology is the first true development in tangential flow filtration for downstream processing of proteins. Cadence turns a technology that used to require the endless recirculation of proteins into a single-pass process, allowing users to concentrate proteins directly. The Cadence technology reduces equipment size, allows for much higher yields, and less degradation of the protein because it is not exposed to the pumping forces.